https://www.business-standard.com/amp/markets/capital-market-news/cipla-receives-usfda-approval-for-protein-bound-paclitaxel-for-injectable-suspension-125041100207_1.html
Cipla receives USFDA approval for Protein-bound Paclitaxel for Injectable Suspension | Capital...
Cipla's Protein-bound Paclitaxel is an AB-rated generic therapeutic equivalent version of Bristol Myers Squibb's Abraxane for Injectable Suspension 100...
protein bound paclitaxelciplareceivesusfdaapproval